GLAUCOMA AND CATARACT RESEARCH LABORATORIES

密歇根大学凯洛格眼科中心建于1985年。在过去的14年里，眼科和视觉科学系的研究人员增加了一倍。我们作为领先的研究中心保持着很高的声誉，已经实现了愿景研究-国家计划中列举的许多NIH目标。我们的NEI美元奖在全国眼科的排名从第17位上升到第4位。这在很大程度上要归功于新的眼科中心提供的环境。我们在与视网膜退行性疾病、青光眼和白内障相关的分子机制研究和遗传学研究方面尤其富有成效，并在这些领域进行临床试验。我们的成功使我们能够吸引优秀的资深和初级科学家加入我们的教职员工，并致力于与青光眼和白内障的分子遗传学基础相关的重大新举措，这是国家计划的优先事项。由于最初的建筑设计无法预测我们当前研究的特定实验室需求，我们正准备翻新凯洛格眼科中心的整个二楼，将临床空间改造为三个实验室和一个相关的共享设备区，包括冷藏室、组织培养室和青光眼和白内障研究研究会议室。拟议中的二楼翻修将为两名新的研究人员提供实验室，并腾出一些空间来缓解我们五楼分子遗传学、视网膜退化和基因治疗研究项目的拥挤状况。

The Kellogg Eye Center at the University of Michigan was build in 1985. During the past 14 years the research faculty in the D4epartment of Ophthalmology and Visual Sciences has doubled. We maintain a strong reputation as a leading research center that has accomplish4ed many of the NIH goals enumerated in Vision Research-A National Plan. Our NEI dollar award national ranking has moved from 17th to 4th place among ophthalmology departments. Much of this we owe to the environment offered by the new Eye Center. We have been particularly productive in molecular mechanisms research and the genetic research related to degenerative disorders of the retina, glaucoma, and cataracts, as well as performing clinical trials in these fields. Our successes have allowed us to attract outstanding senior and junior scientists to our faculty, and to pursue major new initiatives related to the molecular genetic basis of glaucoma and cataract, which are high priorities of the National Plan. Since the original building design could not have forecast the specific laboratory needs for our current research we are preparing to renovated the entire second floor of the Kellogg Eye Center to convert clinical space into three laboratories and an associated shared equipment area comprising a cold room, tissue culture room, and research conference room for glaucoma and cataract research. The proposed renovations on the second floor will provide laboratories for two new investigators, as well as free up some of the space needed to relieve crowding in our fifth floor research programs in molecular genetics, retinal degenerations and gene therapy.